How to Titrate Off Wellbutrin: Steps and Symptoms

Tapering off Wellbutrin (bupropion) generally involves reducing your dose in steps over several weeks rather than stopping all at once. While bupropion has a reputation for causing fewer discontinuation problems than many other antidepressants, withdrawal symptoms do occur, and abrupt cessation has been linked to irritability, anxiety, insomnia, and physical discomfort. The specifics of a safe taper depend on your current dose, how long you have been taking the medication, and individual factors like kidney function and genetics that influence how quickly your body clears the drug.

Why You Should Not Just Stop Taking It

Bupropion works primarily by blocking the reuptake of two brain chemicals: norepinephrine and dopamine. Unlike SSRIs, it does not have a major direct effect on serotonin reuptake.¹ This distinction matters because serotonin-heavy antidepressants like paroxetine and venlafaxine are notorious for harsh withdrawal. Bupropion’s different mechanism led many clinicians to assume it carried little discontinuation risk. That assumption is not entirely wrong, but it is not entirely right either.

When you take bupropion consistently, your brain adapts. Research in animal models shows that sustained dosing changes the firing patterns of both serotonin and norepinephrine neurons over a period of days to weeks, with some receptor systems gradually desensitizing to compensate for the drug’s presence.² When you yank the drug away suddenly, those adapted systems are left in a state they were not designed to be in without the medication propping them up. The result can be a cluster of uncomfortable symptoms while the brain recalibrates.

A published case report documented what happened when a 32-year-old man abruptly stopped bupropion after using it for nicotine dependence: he developed irritable mood, anxiety, sleeplessness, headache, and generalized body aches. The authors specifically recommended a slow taper for discontinuation and noted the importance of watching for withdrawal symptoms.³ That single case report does not define the entire landscape, but it illustrates a pattern clinicians have encountered more broadly.

What a Standard Taper Looks Like

There is no single FDA-mandated tapering protocol for bupropion. In clinical practice, tapering typically means stepping down to the next lower available dose for a few weeks before making another reduction. Wellbutrin XL (the once-daily extended-release formulation) comes in 150 mg and 300 mg tablets, so the most common approach for someone on 300 mg XL is straightforward: drop to 150 mg XL for two to four weeks, then stop. If you are on 450 mg, you would step down to 300 mg first, hold there, then drop to 150 mg, and then discontinue.

For the SR (twice-daily sustained-release) version, the process is similar but involves adjusting both the dose size and sometimes the number of daily doses. Someone taking 150 mg SR twice a day might first drop to 150 mg once daily for a couple of weeks. The immediate-release form, dosed two or three times a day, offers more flexibility for small reductions but is less commonly prescribed now.

A key practical limitation is that you cannot cut or crush Wellbutrin XL or SR tablets. These formulations rely on their coatings to release the drug slowly, and breaking them defeats that mechanism, potentially dumping the full dose at once. This limits your ability to make fine-grained dose adjustments using commercially available tablets alone. If your prescriber wants you to taper in smaller increments than the available tablet strengths allow, you may need a compounding pharmacy to prepare custom doses. Some insurance plans cover compounded medications, while others do not or require additional paperwork from your doctor documenting medical necessity.

The duration of a taper varies. Two to four weeks at each step is a common clinical starting point, but people who have been on bupropion for years, or who have a history of difficult withdrawals from other medications, may benefit from a longer, slower approach.

Symptoms You Might Experience

Bupropion discontinuation symptoms tend to be milder and less common than those associated with SSRIs and SNRIs, but they are real. The symptoms documented in the clinical literature include:

• Mood changes: irritability, anxiety, and low mood that feels distinct from your original depression
• Sleep disruption: difficulty falling or staying asleep
• Physical discomfort: headaches and generalized aches and pains
• Fatigue: a sense of low energy or lethargy, sometimes accompanied by brain fog

These symptoms were specifically reported in the case of abrupt discontinuation described earlier, where the patient experienced irritable mood, anxiety, sleeplessness, headache, and body aches.³ Broader reviews of antidepressant discontinuation note that withdrawal from psychiatric medications can also include sensory disturbances, movement-related symptoms, and hyperarousal, though these are more commonly associated with serotonin-based antidepressants than with bupropion.

Symptom onset depends partly on how quickly the drug leaves your system. Bupropion’s half-life is roughly 21 hours for the parent compound, but its active metabolites stick around longer. For most people, withdrawal symptoms start within a few days of a dose reduction. They typically peak within the first one to three weeks and then gradually fade. If symptoms are severe or persistent, that is a signal to talk to your prescriber about slowing down the taper or briefly going back up to the previous dose.

Who Is More Likely to Have a Rough Time

Not everyone who stops bupropion will notice withdrawal symptoms. Several factors tip the scales toward a harder experience. A systematic review of antidepressant withdrawal risk found that longer duration of use was associated with a higher incidence and greater severity of withdrawal effects, consistent with the idea that the brain adapts more deeply the longer it is exposed to a drug. Higher doses showed a weaker but still present association with increased risk.⁴

A meta-analysis examining withdrawal across many antidepressants identified additional risk factors: being female, being younger, having experienced side effects early in treatment, abruptly stopping the medication rather than tapering, and having slower drug clearance.⁵ That last point about clearance is worth lingering on, because how fast your body eliminates bupropion varies quite a lot from person to person.

Past experience is also predictive. If you have previously struggled with withdrawal symptoms when stopping a medication, whether bupropion or something else, you are more likely to encounter them again.⁴ Telling your prescriber about any previous discontinuation difficulties helps them calibrate your taper plan.

How Kidney Function and Genetics Change the Equation

Your body breaks down bupropion mainly through a liver enzyme called CYP2B6, and then your kidneys help clear the drug and its byproducts. If either of those systems works differently from average, the drug can linger longer or shorter than expected, which directly affects how you should taper.

A pharmacokinetic study of people with kidney impairment found that bupropion levels were roughly double those seen in people with normal kidney function: the area under the curve (a measure of total drug exposure) was about 126% higher, peak concentration was 86% higher, and the drug’s half-life was about 140% longer.⁶ In practical terms, if your kidneys are not working at full capacity, the drug takes much longer to wash out of your system. That could mean you experience withdrawal symptoms on a delay, or that a taper schedule designed for someone with normal kidneys moves too fast for you.

Genetics add another layer. Bupropion is converted by CYP2B6 into hydroxybupropion, an active metabolite that contributes to the drug’s effects. People who carry certain genetic variants of CYP2B6, particularly the *6 variant, produce less hydroxybupropion. A meta-analysis found that carriers of CYP2B6*6 had meaningfully reduced exposure to both hydroxybupropion and the combined active substance compared with people who metabolize the drug normally.⁷ Earlier research confirmed that people with reduced-function CYP2B6 alleles showed significantly lower peak and steady-state concentrations of this metabolite.⁸

What does this mean for tapering? If you are a poor or intermediate metabolizer, you may effectively be getting a different drug profile than someone else on the same dose. The parent compound sticks around longer, the active metabolite is produced in smaller amounts, and the overall pharmacokinetic picture shifts. This does not automatically make withdrawal worse or better, but it means a one-size-fits-all taper schedule may not fit you. Pharmacogenomic testing, if available, can give your prescriber more information to work with. And if you have ever felt that bupropion hit you harder than expected or that side effects were unusually pronounced, slow metabolism could be a factor worth discussing before you start tapering.

The Hyperbolic Tapering Concept

Most standard tapers are linear: you drop from 300 mg to 150 mg, then from 150 mg to zero, in equal steps. Each reduction cuts the dose by the same absolute amount. But the relationship between dose and what the drug actually does in your brain is not linear. Going from 300 mg to 150 mg removes a smaller fraction of the drug’s receptor activity than going from 150 mg to zero. The last bit of medication you are taking may be doing proportionally more neurochemical work than the first bit you removed.

This insight has led researchers to advocate for hyperbolic tapering, where dose reductions get progressively smaller as you go lower. Instead of halving the dose each time, you might reduce by a smaller and smaller amount: say, 300 to 200 to 125 to 75 to 40 to 20 mg, with each step representing a roughly proportional decrease in receptor occupancy rather than a flat milligram cut. A study of antidepressant tapering outcomes found that daily small-step hyperbolic tapers produced less withdrawal than weekly larger-step reductions, particularly over one-, two-, or three-month tapering courses.⁹

The challenge with hyperbolic tapering for Wellbutrin is practical. You cannot easily get bupropion in doses like 75 mg or 40 mg XL from a standard pharmacy. The immediate-release form does come in 75 mg tablets, which offers some flexibility, but achieving very small doses at the tail end of a taper usually requires a compounding pharmacy to prepare custom capsules or liquid formulations. Despite the practical hassle, this approach may be worth pursuing if you have tried a standard taper and found the final step from 150 mg to zero intolerable.

Randomized trial evidence specifically comparing linear and hyperbolic tapering strategies is still being gathered. A recent protocol for a controlled trial aims to compare these two approaches head-to-head in adults with remitted depression.¹⁰ Until those results are in, the evidence favoring hyperbolic tapering comes primarily from observational data and pharmacological reasoning rather than large randomized trials.

Telling Withdrawal Apart from Relapse

One of the trickiest parts of stopping any antidepressant is figuring out whether the low mood, anxiety, or irritability you are feeling is withdrawal or your original condition coming back. This distinction matters enormously because the response is opposite: withdrawal means you should stay the course (and possibly slow down), while relapse might mean you need to restart the medication at a therapeutic dose.

Clinicians generally look at three things to tell these apart: timing, symptom type, and how quickly symptoms resolve if you resume the drug. Withdrawal symptoms usually appear within days of a dose reduction, while relapse tends to set in over weeks to months. A study that tracked symptom trajectories after antidepressant discontinuation found that withdrawal symptom scores peaked around day 22, while depression symptom scores peaked about a week later, around day 28.¹¹ That gap is modest, which explains why the two get confused so often.

Symptom type offers another clue. Withdrawal often comes with physical symptoms alongside psychological ones, including dizziness, nausea, electric-shock sensations (the infamous “brain zaps”), and flu-like aches. When physical and psychological symptoms appear together, withdrawal is the more likely explanation. Ten symptoms in one study were found exclusively in the discontinuation group, suggesting they could serve as markers to distinguish withdrawal from relapse.¹¹

Restarting the medication provides a third diagnostic test. If symptoms are caused by withdrawal, they tend to resolve quickly, often within a week of going back on the drug. Relapse takes longer to respond. However, this reinstatement test works best when you act early. Waiting weeks or months after withdrawal symptoms begin before restarting the medication makes reinstatement less reliably effective.¹²

One reassuring finding from the research: withdrawal symptoms do not appear to systematically trigger or get misdiagnosed as relapse. When researchers examined whether withdrawal symptoms predicted who would eventually relapse, they found no significant difference in the pattern of overlapping symptoms between people who relapsed and those who did not.¹¹ The two processes appear to be genuinely separate, even when they feel similar in the moment.

When Symptoms Drag On

The traditional clinical view was that antidepressant withdrawal lasts one to three weeks and then resolves. Researchers and patient communities have pushed back on that timeline. Some people report symptoms persisting for months after stopping, a phenomenon sometimes called post-acute withdrawal syndrome or protracted withdrawal. A systematic review examining this topic acknowledged that online peer-support communities have generated thousands of accounts of prolonged symptoms, though the review also flagged the limitations of that data: selection bias, lack of clinical verification, and inability to confirm tapering schedules or original diagnoses.¹³

Online patient communities have played an outsized role in shaping awareness of prolonged withdrawal. The founder of one prominent community documented lessons from helping thousands of people taper off psychiatric medications, covering common adverse reactions, tapering techniques, and strategies for coping with withdrawal symptoms that exceed the expected timeline.¹⁴ The clinical research literature was initially dismissive of these reports, but recognition of protracted withdrawal has grown. The older assumption that withdrawal should resolve quickly now coexists with the acknowledgment that this is not always the case, a shift in understanding that a BJPsych Advances review explicitly addressed by noting that duration alone is no longer considered a reliable criterion for distinguishing withdrawal from relapse.¹²

If you are weeks or months into a completed taper and still feeling off, this does not automatically mean you need to go back on the medication. It also does not mean the symptoms are imaginary. Discussing the timeline and symptom pattern with a prescriber who takes withdrawal seriously is the most productive step. Some people find that reinstating a small dose and then tapering more slowly resolves the problem; others ride out the symptoms with supportive measures. The evidence base for managing protracted withdrawal is thin, and much of what guides clinical decisions in this territory comes from accumulated clinical experience rather than randomized trials.

Drug Interactions That Complicate Tapering

Bupropion does not exist in pharmacological isolation. It is metabolized by CYP2B6, but it also powerfully inhibits another enzyme, CYP2D6. If you are taking other medications that rely on CYP2D6 for their metabolism, stopping bupropion can indirectly affect the levels of those other drugs. For example, if you take a medication whose blood levels were being kept higher than usual because bupropion was inhibiting the enzyme that clears it, stopping bupropion may cause that other drug’s levels to drop. This is a conversation to have with your prescriber before starting a taper, not after.

Going the other direction, if you start a new medication during your taper that inhibits CYP2B6, bupropion may clear more slowly than expected, effectively giving you a higher functional dose than your tablet count suggests. Strong CYP2B6 inhibitors include certain antifungal and antiretroviral drugs. The practical takeaway is that any medication change during a bupropion taper should be flagged with your pharmacist or doctor so that the expected clearance timeline stays accurate.

Alcohol is another factor people underestimate. Bupropion lowers the seizure threshold, and alcohol withdrawal does the same. If you drink regularly and are also tapering bupropion, the combined effect on seizure risk is worth discussing with your prescriber, even if your drinking feels moderate. This is not a reason to avoid tapering, but it is a reason to be honest about your alcohol use during the process.